0001209191-19-049684.txt : 20190916 0001209191-19-049684.hdr.sgml : 20190916 20190916172841 ACCESSION NUMBER: 0001209191-19-049684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190912 FILED AS OF DATE: 20190916 DATE AS OF CHANGE: 20190916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oien Jessica CENTRAL INDEX KEY: 0001760712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 191095470 MAIL ADDRESS: STREET 1: C/O CIDARA THERAPEUTICS, INC. STREET 2: 6310 NANCY RIDGE DR, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-12 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001760712 Oien Jessica C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DR, STE 101 SAN DIEGO CA 92121 0 1 0 0 General Counsel & Secretary Common Stock 2019-09-12 4 A 0 2800 0.00 A 8800 D Restricted Stock Unit 2019-09-12 4 M 0 2800 0.00 D Common Stock 2800 11200 D This transaction relates to the vesting of shares upon the achievement of various clinical and corporate milestones that were previously reported in Table II of the Reporting Person's Form 4 filed 2/1/19. Restricted stock units convert into common stock on a one-for-one basis. A portion of the shares vest upon the achievement of various clinical and corporate milestones. /s/ Jessica Oien 2019-09-16